home
features
applications
community
stories
news

Menu

home
features
applications
community
stories
news

Congratulations to Sarah Merkling (Pasteur Institute) for her recent Single-Cell Publication.

mars 1, 2021
, 8:28
, news

SuivantRNAssist Limited and QCMD Agree Collaboration for vivoPHIX™ Biomolecule Stabilization TechnologySuivant

Share this post

Contact us

If you would like to receive news about RNAssist and associated products, evaluate our ground-breaking fixative and stabiliser, carryout tissue dissociation and single-cell preparation or would simply like to exchange comments and results with more than 180 other members of the RNAssist User Community please send a message. We look forward to meeting you!

Your Name

Your Email

Your message

vivoPHIX™, genoPHIX™, virusPHIX™ and virusPHIX-P9™ , as well as virus and viral inactivation, virus transport media (VTM), SARS-CoV-2, Covid-19, diagnostics, biosafety, LAMP testing, Lateral Flow, Antigen, Serology, antibody testing, immunofluorescence, scRNA-seq, scDNA-seq, tissue dissociation, saliva, swab, blood, plasma, EQA and molecular controls .

This non-toxic formalin-free tissue fixative ensures the preservation of both tissue histomorphology and biomolecules. RNAssist prevents the degradation of proteins, DNA, RNA and mRNA. When compared to products such as RNAlater ®, PAXgene Tissue Systems or Allprotect ® Tissue Reagent, RNA demonstrated high-quality RNA stabilization and protection in the context of long-term tissue storage and archival . Designed for room temperature use, RNAssist is compatible with routine paraffin-embedding procedure, pathology staining – (H&E, immunohistochemistry (IHC) , in situ hybridization (IS) – and molecular analysis : RT-PCR, WB, next-geneneration sequencing, …